| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
AlloVir Inc (NASDAQ: ALVR)
ALVR Technical Analysis
5
| As on 4th Feb 2025 ALVR STOCK Price closed @ 10.06 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.29 & Strong Buy for SHORT-TERM with Stoploss of 2.32 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALVRSTOCK Price
| Open | 10.19 | Change | Price | % |
| High | 10.37 | 1 Day | 0.26 | 2.65 |
| Low | 9.71 | 1 Week | -0.05 | -0.49 |
| Close | 10.06 | 1 Month | 9.60 | 2086.96 |
| Volume | 46808 | 1 Year | 7.44 | 283.97 |
| 52 Week High 10.19 | 52 Week Low 0.38 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 118.65 | 1.71% |
| TNXP | 0.15 | -21.05% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| BHAT | 0.04 | -20.00% |
| PONO | 1.72 | 2.38% |
| TELL | 1.00 | 0.00% |
| PLUG | 1.95 | 4.84% |
| LCID | 2.93 | 4.64% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ALVR Daily Charts |
ALVR Intraday Charts |
Whats New @ Bazaartrend |
ALVR Free Analysis |
|
|
ALVR Important Levels Intraday
| RESISTANCE | 11.33 |
| RESISTANCE | 10.92 |
| RESISTANCE | 10.67 |
| RESISTANCE | 10.42 |
| SUPPORT | 9.70 |
| SUPPORT | 9.45 |
| SUPPORT | 9.20 |
| SUPPORT | 8.79 |
ALVR Forecast February 2025
| 4th UP Forecast | 13.62 |
| 3rd UP Forecast | 12.48 |
| 2nd UP Forecast | 11.77 |
| 1st UP Forecast | 11.07 |
| 1st DOWN Forecast | 9.05 |
| 2nd DOWN Forecast | 8.35 |
| 3rd DOWN Forecast | 7.64 |
| 4th DOWN Forecast | 6.5 |
ALVR Weekly Forecast
| 4th UP Forecast | 12.22 |
| 3rd UP Forecast | 11.53 |
| 2nd UP Forecast | 11.10 |
| 1st UP Forecast | 10.67 |
| 1st DOWN Forecast | 9.45 |
| 2nd DOWN Forecast | 9.02 |
| 3rd DOWN Forecast | 8.59 |
| 4th DOWN Forecast | 7.90 |
ALVR Forecast2025
| 4th UP Forecast | 29.48 |
| 3rd UP Forecast | 23.25 |
| 2nd UP Forecast | 19.4 |
| 1st UP Forecast | 15.55 |
| 1st DOWN Forecast | 4.57 |
| 2nd DOWN Forecast | 0.72 |
| 3rd DOWN Forecast | -3.13 |
| 4th DOWN Forecast | -9.36 |
AlloVir Inc ( NASDAQ USA Symbol : ALVR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALVR Business Profile
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is Viralym-M, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. Its preclinical and clinical development product candidates include ALVR106 for respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108 to treat human herpesvirus-8, including Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's diseases. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was founded in 2013 and is based in Cambridge, Massachusetts. Address: 139 Main Street, Cambridge, MA, United States, 02142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service